Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive DisorderMichael E. Thase, Hans Eriksson, Carole Augustine et al.|The Journal of Clinical Psychiatry|2015Cited by 179
Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to AntidepressantsMichael E. Thase, Hans Eriksson, James M. Youakim et al.|The Journal of Clinical Psychiatry|2015Cited by 164